Onkologi Pediatrik onkolog anak Terbaik - TOP-81 dokter

Dr. Betül Tavil adalah seorang profesor hematologi dan onkologi pediatrik, seorang ahli kelas dunia dalam transplantasi sumsum tulang untuk anak-anak.

Mengapa pasien percaya Dr. Tavil:

• Dokter dengan hasil yang luar biasa — berhasil menangani lebih dari 500 anak dengan leukemia dan melakukan transplantasi sumsum tulang pada lebih dari 100 anak.
• Spesialis dalam gangguan darah terlangka pada anak-anak: eritropoietik porfiria kongenital, imunodefisiensi, penyakit darah genetik.
• Ilmuwan peraih penghargaan — menerima Penghargaan Masyarakat Hematologi Turki atas pencapaian luar biasa dalam pengobatan kanker darah anak-anak.
• Lebih dari 150 publikasi di jurnal internasional dengan 1.700+ sitasi — terus mengembangkan metode pengobatan baru.
• Ahli dalam transplantasi sumsum tulang yang kompleks untuk penyakit ganas dan non-ganas pada anak-anak.
• 28 tahun pengalaman di pusat-pusat terkemuka — Universitas Hacettepe, Rumah Sakit Anak-anak Ankara, Memorial Şişli.
• Menyediakan konsultasi online — kesempatan untuk mendapatkan pendapat ahli dari seorang hematologis pediatrik yang luar biasa tanpa harus meninggalkan rumah.

Pendidikan :

Universitas Istanbul, Fakultas Kedokteran Istanbul, September 2004 – Juli 2010

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Ortopedi, Residen Februari 2011 - April 2011

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Oftalmologi, Residen Agustus 2011 - Maret 2016

Universitas Thomas Jefferson, Wills Eye Institute, Departemen Onkologi Okular, Pengamatan Agustus 2012 - September 2012

Kementerian Kesehatan Turki, Rumah Sakit Negara Hakkari, Klinik Oftalmologi, Dokter Spesialis Mata Juli 2016 – Maret 2018

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Asisten Profesor, Maret 2018 – Oktober 2021

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Oktober 2021 – Desember 2021

Universitas Istanbul Yeni Yuzyil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Januari 2022 – sekarang

Kualifikasi Pendidikan :

1. Penilaian ilmu dasar oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2017

2. Ujian Optik & Refraksi International Council of Ophthalmology (ICO) lulus pada April 2017

3. Ujian Ilmu Klinis dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2018

4. Menerima beasiswa ICO-STAAR Bedah Tiga Bulan dalam Vitreo-Retina di University of Kansas, Fakultas Kedokteran, Departemen Oftalmologi di Prairie Village, KS, Amerika Serikat di bawah pengawasan Prof. Radwan Aijlan dari 6 April 2020 hingga 5 Juli 2020.

5. Ujian Lanjutan dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada Juli 2020.

6. United States Medical Licensing Examination (USMLE) Step 1 lulus pada 7 Januari 2021 dengan 221 poin.

7. United States Medical Licensing Examination (USMLE) Step 2 CK lulus pada 25 Agustus 2021 dengan 214 poin.

Presentasi & Poster :

1. Kongres Oftalmologi Nasional ke-47, Efektivitas terapi fotodinamik pada hemangioma koroid sirkumsirkum, Presentasi lisan, Ozer MD, Tuncer S, November 2013, Antalya, Turki.

2. Kongres Oftalmologi Nasional ke-48, Fitur klinis dan hasil pengobatan rhabdomyosarcoma oftalmik primer: Pengalaman pusat tersier, Ozer MD, Ulas MG, Tuncer S, Presentasi lisan, November 2014, Antalya, Turki

3. Pertemuan ISOO 2015, Hasil Jangka Panjang Terapi Kombinasi (Suntikan Perilesional dan Topikal) Interferon Alpha-2b dalam Manajemen Neoplasia Skuamosa Permukaan Mata, Tuncer S, Ozer MD, Presentasi lisan, Juni 2015, Paris, Prancis

4. Kongres Oftalmologi Nasional ke-49. Pola presentasi klinis sindrom Vogt-Koyanagi-Harada pediatrik dan hasil tindak lanjut jangka panjang, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Presentasi lisan, November 2015, Istanbul, Turki.

5. Kongres Oftalmologi Nasional ke-49, Ketebalan kornea sentral dan dimensi cakram optik pada pasien glaukoma, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turki.

6. Kongres Oftalmologi Nasional ke-49, Analisis lapisan serat saraf retina dan ketebalan koroid pada pasien dengan sklerosis sistemik untuk mengidentifikasi faktor risiko potensial untuk glaukoma tekanan normal, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turki.

7. Kongres Oftalmologi Nasional ke-50, Pengobatan degenerasi makula terkait usia dengan Ranibizumab intravitreal: Pengalaman kehidupan nyata, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Presentasi lisan, November 2016, Antalya, Turki

8. Kongres Oftalmologi Nasional ke-51, Komplikasi jarang terlihat dari operasi katarak: Hematoma Endokapsular, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turki

9. Kongres Oftalmologi Nasional ke-52, Nanophthalmos dengan Lipatan Makula, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

10. Kongres Oftalmologi Nasional ke-52, Fitur Klinis dan Metode Pengobatan Kasus Selulitis Orbital, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

11. Kongres Oftalmologi Nasional ke-52, Seri Kasus: Luka Bakar Kimia Mata, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turki

12. Kongres Oftalmologi Nasional ke-52, Kehilangan Pendengaran Sensorineural yang Mempengaruhi Frekuensi Rendah pada Pasien dengan Pseudoeksfoliasi, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turki

13. Kongres Oftalmologi Nasional ke-52, Intubasi tabung silikon oleh stent Ritleng pada anak-anak di atas dua tahun dengan obstruksi saluran nasolakrimal, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turki

14. Kongres Oftalmologi Nasional ke-52, Tampilan Bintik Merah Ceri di Makula dan Alkaptonuria: Laporan Kasus, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

15. Kongres Oftalmologi Nasional ke-52, Komplikasi Langka pada Implantasi Deksametason Intravitreal: Migrasi Implan ke Ruang Anterior, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

16. Kongres Oftalmologi Nasional ke-52, Efek Tetes Mata Koenzim Q10 pada Penyembuhan Luka Kornea dalam Pengobatan Keratitis Bakteri, Batur M, Seven E, Tekin S, Ozer MD, Presentasi lisan, November 2018, Antalya, Turki

17. Kongres Euretina ke-19, Efek produksi humor aquous yang berkurang pada potensi pertumbuhan bakteri di mata kelinci, Batur M, Ozer M, Tekin S, Presentasi lisan, September 2019, Paris, Prancis

18. Kongres Oftalmologi Nasional ke-53, Evaluasi fitur klinis pasien dengan hifema akibat trauma tumpul, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Presentasi lisan, November 2019, Antalya, Turki

19. Kongres Oftalmologi Nasional ke-53, Kepatuhan terhadap terapi tetes mata dan hubungan kepatuhan dengan perkembangan pada pasien glaukoma, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turki

20. Kongres Oftalmologi Nasional ke-53, Kehilangan penglihatan bilateral mendadak-sementara setelah pelepasan kateter venosa sentral, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

21. Kongres Oftalmologi Nasional ke-53, Evaluasi klinis terapi fotokoagulasi laser Argon pada pasien dengan robekan retina, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

22. Kongres Oftalmologi Nasional ke-53, Kerusakan makula akibat epilasi laser: laporan kasus, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turki

23. Kongres Oftalmologi Nasional ke-53, Makulopati Fototoksik akibat Penggunaan Berlebihan Inframerah Iluminator Bersama Scope Penglihatan Malam Tangan, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turki

24. Kongres Oftalmologi Nasional ke-54, Ophthalmoplegia internal setelah infeksi cacar air, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turki.

Pengalaman Kerja :

1. Studi Tahap II untuk Menganalisis Sarilumab dalam Uveitis Non-Infeksius (SARILNIUSATURN-Sanofi), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

2. Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-A&C-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

3. Studi Acak, Tertutup Ganda, Dikendalikan Plasebo tentang Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-B-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

4. Studi 12 bulan, acak, tertutup ganda, dikendalikan semu, multicenter untuk mengevaluasi efikasi dan keamanan injeksi intravitreal ranibizumab 0,5 mg akibat edema makula akibat faktor pertumbuhan endotel vaskular (VEGF) (RFB002-Novartis), Peneliti sub-injeksi (Peneliti Utama: Prof. Dr. Nur Kir)

5. Studi fase III multicenter, acak, tertutup ganda, dikendalikan semu untuk menilai efikasi dan keamanan lampalizumab yang diberikan secara intravitreal kepada pasien dengan atrofi geografis sekunder akibat degenerasi makula terkait usia (GX29176-Roche), Fotografer (Peneliti Utama: Prof. Dr. Nur Kir)

Dipilih sebagai anggota aktif Asosiasi Oftalmologi Turki, Dewan Dokter Muda, 2020 - sekarang

Pendidikan

• Fakultas Kedokteran Ege 1978
• Spesialisasi di bidang Pediatri 1982
• Subspesialisasi Onkologi Pediatrik 2002 (Fakultas Kedokteran EU)
• Hematologi dan Onkologi Pediatrik 2012 (Fakultas Kedokteran EU)
• Wakil Kepala Klinik 1988 Tepecik EAH
• Kepala Klinik 1993 Tepecik EAH
• Asosiasi Profesor 1995
• Profesor 2002
• Anggota Fakultas Fakultas Kedokteran Ege U. 1998 – 2022
• Departemen Kedokteran Anak Fakultas Kedokteran EU 2009-2018
• Anggota Dewan Perencanaan dan Koordinasi Pendidikan Tepecik (1993-1998)
• Ketua Komite Etik Rumah Sakit SSI Tepecik (1996-1998)
• Masyarakat Hematologi Anak Turki "Wakil Ketua Kelompok Kerja Transplantasi Sumsum Tulang" (2002-2006)
• Masyarakat Hematologi Anak Turki "Kelompok Kerja Transplantasi Sumsum Tulang" (2006-2008)
• Masyarakat Hematologi Anak Turki - Bertanggung jawab atas Sistem Registri Data "Online" Transplantasi Sumsum Tulang 2007-sekarang.
• Ketua Komisi Kedokteran Regeneratif dan Sel Punca Universitas Ege, 2011-2021

Keanggotaan Institusi

• Asosiasi Medis Turki Cabang İzmir dan Kocaeli
• Asosiasi Pediatri Nasional Turki - İzmir
• Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT); Unit Transplantasi Sumsum Tulang Pediatrik Universitas Ege terakreditasi oleh Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT) pada Juni 2007.
• Masyarakat Hematologi Anak Turki - Anggota Dewan selama dua periode (2005-2009)
• Masyarakat Hematologi Turki - Anggota Dewan selama dua periode (2001/2005)
• Asosiasi Onkologi Pediatrik Turki
• Yayasan Transplantasi Sumsum Tulang (KITVAK) Anggota Dewan Pengawas

Unit yang Didirikannya                        

1- Klinik Onkologi Pediatrik Rumah Sakit SSI Tepecik (1990) 
2- Unit Transplantasi Sumsum Tulang Pediatrik Rumah Sakit SSI Tepecik (1992) 
3- Unit Transplantasi Sumsum Tulang Pediatrik Fakultas Kedokteran EU (1998) 
4- PENDIRI JURNAL PENELITIAN PEDIATRIK, 2014; aplikasi SCI dilakukan pada 2022. 

Unit Transplantasi yang Dia Berkontribusi dalam Pendirian                        

1. Unit Transplantasi Sumsum Tulang Pediatrik İzmir BUÇH EAH (2019) 
2. Unit Transplantasi Sumsum Tulang Pediatrik Ümraniye EAH (2020) 
3. Unit Transplantasi Sumsum Tulang Pediatrik Kanuni Sultan Süleyman EAH (2020) (Dipindahkan ke Çam Sakura EAH)

Penghargaan

• Parameter trombotik pada pasien transplantasi sel punca sumsum tulang, Kongres Hematologi Pediatrik, Trabzon 2003
• Antigen CD133 dalam Sel Punca: Kongres Hematologi Pediatrik 2005. Penghargaan penelitian
• Peran reseptor Toll seperti pada pasien neutropenik febril, penghargaan poster terbaik. Kongres Hematologi Turki 2008, Çeşme-İzmir
• Kegiatan transplantasi sel punca pediatrik nasional- Penghargaan presentasi lisan kedua, Kongres Transplantasi Sel Punca Masyarakat Hematologi Turki, 2022, Antalya

Publikasi

Kansoy S. "Transplantasi Sumsum Tulang dan Sel Punca Kesehatan Anak dan Penyakit, edisi pertama, Percetakan Fakultas Kedokteran EU, 1999, İzmir

Kansoy S. Transplantasi sumsum tulang pada Thalassemia Major III. Buku Hari Thalassemia Aegea, 2000, Izmir

Kansoy S. Standar Pusat KIT Pediatrik di Turki. Leukemia Akut Anak, Antalya 2000: 73-5

Kansoy S. Efek Samping Jangka Panjang pada Anak. Edisi khusus Jurnal Transplantasi Sumsum Tulang Klinik Turki. 2003

Kansoy S. Aplikasi Sel Punca dalam Transplantasi Sumsum Tulang dan Sel Punca. Buku Kursus Keperawatan Onkologi Pediatrik, İzmir, 2005

Kansoy S. Darah Tali Pusat sebagai Sumber Sel Punca. Edisi Khusus Sel Punca. Klinik Turki, 2008

Kansoy S. Transplantasi Sel Punca pada Limfoma. Buku Pediatri Umum, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplantasi Sumsum Tulang pada Anak. Pediatri, 2014 dan 2017

Kansoy S. Rhabdomyosarcoma. Pediatri, 2014 dan 2017

Kansoy S. Pendekatan kepada Anak dengan Kanker Berdasarkan Temuan Klinis. Pediatri, 2014 dan 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Penyakit Onkologis. Pediatri (Ed. A. Cura), 641-672, Percetakan Universitas Ege, İzmir, 1999.  (1.05 poin)

Kansoy S, M.Kantar. Pemeriksaan Kepala, Wajah, dan Mata. Pemeriksaan Fisik Prostetik Pediatrik dan Informasi Gejala (Ed. A.Cura)

Kantar M. Masalah Darurat Metabolik dalam Onkologi. Darurat Onkologi dan Perawatan Dukungan pada Anak (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Transplantasi Darah Tali Pusat di Turki. HEMATOLOGIST, 2016

Kansoy S. Tumor Sistem Saraf Pusat pada Anak Pediatri, 2014 dan 2017

Leukemia mieloblastik akut pada anak dan pengobatannya. Buku Ajar Onkologi Pediatrik, Turki Poplack, 2020

Kegiatan transplantasi sel punca pediatrik nasional, 2020

Indikasi transplantasi sel punca anak, Klinik Turki - Buku Internasional 2020

Selain studi dan makalah di jurnal internasional yang diterbitkan dalam jumlah besar, dia terlibat dalam studi multinasional internasional di beberapa jurnal dengan nilai dampak tinggi.

Pediatric surgeon

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

⸻

EDUCATION

2022

Associate Professor

2017 - 2020, Istanbul/Turkey

University of London, School of Hygiene and Tropical Medicine

Master’s Program in Clinical Trials

2013, Istanbul/Turkey

AMERICAN HOSPITAL, IVF UNIT

Ministry of Health Subspecialty Training in Reproductive Medicine

2005 - 2010, Istanbul/Turkey

İSTANBUL GÖZTEPE TRAINING AND RESEARCH HOSPITAL

Residency in Obstetrics and Gynecology

1998 - 2004, Istanbul/Turkey

İSTANBUL UNIVERSITY, CERRAHPAŞA FACULTY OF MEDICINE

Medical Doctor (M.D.) Education                                                                      

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Dr. Ozden Gul is a general surgeon trained at Istanbul University Cerrahpaşa Faculty of Medicine. She completed her general surgery residency at Haydarpaşa Numune Training and Research Hospital. She has decades of surgical experience and is fluent in English.

Her practice includes gastrointestinal surgery (gallbladder disease, hernias, appendicitis, GI disorders). She also treats endocrine conditions (thyroid, parathyroid, adrenal) and breast disease, both benign and malignant. She manages emergency and trauma cases. She offers minimally invasive laparoscopic surgery.

She has worked at Haydarpaşa Numune, Bakırköy, Taksim First Aid, Uzunköprü State, Keşan State, Beykoz Medical Center, and Medivia Hospital. She is known for meticulous technique and patient-centered care.

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.